Genome-wide screening and identification of long noncoding RNAs and their interaction with protein coding RNAs in bladder urothelial cell carcinoma

Cancer Letters

Volumn 349, Issue 1, 2014, Pages 77-86

  Wang, Longxin ^a   Fu, Dian ^a   Qiu, Yongbin ^a   Xing, Xiaoxiao ^b   Xu, Feng ^a   Han, Conghui ^c   Xu, Xiaofeng ^a   Wei, Zhifeng ^a   Zhang, Zhengyu ^a   Ge, Jingping ^a   Cheng, Wen ^a   Xie, Hai Long ^d  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b Department of Urology Maternal and Children Health Hospital of Nantong City   (China)

^c XUZHOU CENTRAL HOSPITAL   (China)

^d UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Co expression; LncRNA; Long noncoding RNA; Urothelial carcinoma of bladder

Indexed keywords

CODING RNA; LONG UNTRANSLATED RNA; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN P53; RNA; UNCLASSIFIED DRUG; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE; TP53 PROTEIN, HUMAN; TRANSCRIPTOME;

ARTICLE; BIOINFORMATICS; BLADDER CARCINOMA; BLADDER MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC IDENTIFICATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; TRANSITIONAL CELL CARCINOMA; BLADDER; BLADDER TUMOR; GENE EXPRESSION; GENETICS; METABOLISM; PROCEDURES;

CARCINOMA, TRANSITIONAL CELL; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; RNA, LONG NONCODING; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84901038179     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.03.033     Document Type: Article

References (44)

1. National Cancer Institute, "Bladder Cancer", http://www.cancer.gov/cancertopics/types/bladder.
2. Yang L., Parkin D.M., Li L.D., Chen Y.D., Bray F. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br. J. Cancer 2004, 90:2157-2166.
3. Lindgren D., Sjodahl G., Lauss M., Staaf J., Chebil G., Lovgren K., Gudjonsson S., Liedberg F., Patschan O., Mansson W., Ferno M., Hoglund M. Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma. PLoS ONE 2012, 7:e38863.
4. Chekaluk Y., Wu C.L., Rosenberg J., Riester M., Dai Q., Lin S., Guo Y., Mcdougal W.S., Kwiatkowski D.J. Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value. PLoS ONE 2013, 8:e60927.
5. Guo G., Sun X., Chen C., Wu S., Huang P., Li Z., Dean M., Huang Y., Jia W., Zhou Q., Tang A., Yang Z., Li X., Song P., Zhao X., Ye R., Zhang S., Lin Z., Qi M., Wan S., Xie L., Fan F., Nickerson M.L., Zou X., Hu X., Xing L., Lv Z., Mei H., Gao S., Liang C., Gao Z., Lu J., Yu Y., Liu C., Li L., Fang X., Jiang Z., Yang J., Li C., Zhao X., Chen J., Zhang F., Lai Y., Lin Z., Zhou F., Chen H., Chan H.C., Tsang S., Theodorescu D., Li Y., Zhang X., Wang J., Yang H., Gui Y., Wang J., Cai Z. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat. Genet. 2013.
6. Tian F., Xu F., Zhang Z.Y., Ge J.P., Wei Z.F., Xu X.F., Cheng W. Expression of CHD1L in bladder cancer and its influence on prognosis and survival. Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med. 2013.
7. Lauss M., Aine M., Sjodahl G., Veerla S., Patschan O., Gudjonsson S., Chebil G., Lovgren K., Ferno M., Mansson W., Liedberg F., Ringner M., Lindgren D., Hoglund M. DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status. Epigenetics: Official J. DNA Methylation Soc. 2012, 7:858-867.
8. Wolff E.M., Liang G., Jones P.A. Mechanisms of disease: genetic and epigenetic alterations that drive bladder cancer. Nat. Clin. Practice. Urology 2005, 2:502-510.
9. Lindgren D., Frigyesi A., Gudjonsson S., Sjodahl G., Hallden C., Chebil G., Veerla S., Ryden T., Mansson W., Liedberg F., Hoglund M. Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome. Cancer Res. 2010, 70:3463-3472.
10. Kandoth C., Mclellan M.D., Vandin F., Ye K., Niu B., Lu C., Xie M., Zhang Q., Mcmichael J.F., Wyczalkowski M.A., Leiserson M.D., Miller C.A., Welch J.S., Walter M.J., Wendl M.C., Ley T.J., Wilson R.K., Raphael B.J., Ding L. Mutational landscape and significance across 12 major cancer types. Nature 2013, 502:333-339.
11. Xu F., Zhang Q., Cheng W., Zhang Z., Wang J., Ge J. Effect of miR-29b-1* and miR-29c knockdown on cell growth of the bladder cancer cell line T24. J. Int. Med. Res. 2013, 41:1803-1810.
12. Xie P., Xu F., Cheng W., Gao J., Zhang Z., Ge J., Wei Z., Xu X., Liu Y. Infiltration related miRNAs in bladder urothelial carcinoma. J. Huazhong Univ. Sci. Technol. Med. Sci.=Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban=Huazhong keji daxue xuebao. Yixue Yingdewen ban 2012, 32:576-580.
13. Catto J.W., Miah S., Owen H.C., Bryant H., Myers K., Dudziec E., Larre S., Milo M., Rehman I., Rosario D.J., Di Martino E., Knowles M.A., Meuth M., Harris A.L., Hamdy F.C. Distinct microRNA alterations characterize high- and low-grade bladder cancer. Cancer Res. 2009, 69:8472-8481.
14. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigo R., Gingeras T.R., Margulies E.H., Weng Z., Snyder M., Dermitzakis E.T., Thurman R.E., Kuehn M.S., Taylor C.M., Neph S., Koch C.M., Asthana S., Malhotra A., Adzhubei I., Greenbaum J.A., Andrews R.M., Flicek P., Boyle P.J., Cao H., Carter N.P., Clelland G.K., Davis S., Day N., Dhami P., Dillon S.C., Dorschner M.O., Fiegler H., Giresi P.G., Goldy J., Hawrylycz M., Haydock A., Humbert R., James K.D., Johnson B.E., Johnson E.M., Frum T.T., Rosenzweig E.R., Karnani N., Lee K., Lefebvre G.C., Navas P.A., Neri F., Parker S.C., Sabo P.J., Sandstrom R., Shafer A., Vetrie D., Weaver M., Wilcox S., Yu M., Collins F.S., Dekker J., Lieb J.D., Tullius T.D., Crawford G.E., Sunyaev S., Noble W.S., Dunham I., Denoeud F., Reymond A., Kapranov P., Rozowsky J., Zheng D., Castelo R., Frankish A., Harrow J., Ghosh S., Sandelin A., Hofacker I.L., Baertsch R., Keefe D., Dike S., Cheng J., Hirsch H.A., Sekinger E.A., Lagarde J., Abril J.F., Shahab A., Flamm C., Fried C., Hackermuller J., Hertel J., Lindemeyer M., Missal K., Tanzer A., Washietl S., Korbel J., Emanuelsson O., Pedersen J.S., Holroyd N., Taylor R., Swarbreck D., Matthews N., Dickson M.C., Thomas D.J., Weirauch M.T., Gilbert J., Drenkow J., Bell I., Zhao X., Srinivasan K.G., Sung W.K., Ooi H.S., Chiu K.P., Foissac S., Alioto T., Brent M., Pachter L., Tress M.L., Valencia A., Choo S.W., Choo C.Y., Ucla C., Manzano C., Wyss C., Cheung E., Clark T.G., Brown J.B., Ganesh M., Patel S., Tammana H., Chrast J., Henrichsen C.N., Kai C., Kawai J., Nagalakshmi U., Wu J., Lian Z., Lian J., Newburger P., Zhang X., Bickel P., Mattick J.S., Carninci P., Hayashizaki Y., Weissman S., Hubbard T., Myers R.M., Rogers J., Stadler P.F., Lowe T.M., Wei C.L., Ruan Y., Struhl K., Gerstein M., Antonarakis S.E., Fu Y., Green E.D., Karaoz U., Siepel A., Taylor J., Liefer L.A., Wetterstrand K.A., Good P.J., Feingold E.A., Guyer M.S., Cooper G.M., Asimenos G., Dewey C.N., Hou M., Nikolaev S., Montoya-Burgos J.I., Loytynoja A., Whelan S., Pardi F., Massingham T., Huang H., Zhang N.R., Holmes I., Mullikin J.C., Ureta-Vidal A., Paten B., Seringhaus M., Church D., Rosenbloom K., Kent W.J., Stone E.A., Batzoglou S., Goldman N., Hardison R.C., Haussler D., Miller W., Sidow A., Trinklein N.D., Zhang Z.D., Barrera L., Stuart R., King D.C., Ameur A., Enroth S., Bieda M.C., Kim J., Bhinge A.A., Jiang N., Liu J., Yao F., Vega V.B., Lee C.W., Ng P., Shahab A., Yang A., Moqtaderi Z., Zhu Z., Xu X., Squazzo S., Oberley M.J., Inman D., Singer M.A., Richmond T.A., Munn K.J., Rada-Iglesias A., Wallerman O., Komorowski J., Fowler J.C., Couttet P., Bruce A.W., Dovey O.M., Ellis P.D., Langford C.F., Nix D.A., Euskirchen G., Hartman S., Urban A.E., Kraus P., Van Calcar S., Heintzman N., Kim T.H., Wang K., Qu C., Hon G., Luna R., Glass C.K., Rosenfeld M.G., Aldred S.F., Cooper S.J., Halees A., Lin J.M., Shulha H.P., Zhang X., Xu M., Haidar J.N., Yu Y., Ruan Y., Iyer V.R., Green R.D., Wadelius C., Farnham P.J., Ren B., Harte R.A., Hinrichs A.S., Trumbower H., Clawson H., Hillman-Jackson J., Zweig A.S., Smith K., Thakkapallayil A., Barber G., Kuhn R.M., Karolchik D., Armengol L., Bird C.P., de Bakker P.I., Kern A.D., Lopez-Bigas N., Martin J.D., Stranger B.E., Woodroffe A., Davydov E., Dimas A., Eyras E., Hallgrimsdottir I.B., Huppert J., Zody M.C., Abecasis G.R., Estivill X., Bouffard G.G., Guan X., Hansen N.F., Idol J.R., Maduro V.V., Maskeri B., McDowell J.C., Park M., Thomas P.J., Young A.C., Blakesley R.W., Muzny D.M., Sodergren E., Wheeler D.A., Worley K.C., Jiang H., Weinstock G.M., Gibbs R.A., Graves T., Fulton R., Mardis E.R., Wilson R.K., Clamp M., Cuff J., Gnerre S., Jaffe D.B., Chang J.L., Lindblad-Toh K., Lander E.S., Koriabine M., Nefedov M., Osoegawa K., Yoshinaga Y., Zhu B., de Jong P.J. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447:799-816.
15. Khachane A.N., Harrison P.M. Mining mammalian transcript data for functional long non-coding RNAs. PLoS ONE 2010, 5:e10316.
16. Derrien T., Johnson R., Bussotti G., Tanzer A., Djebali S., Tilgner H., Guernec G., Martin D., Merkel A., Knowles D.G., Lagarde J., Veeravalli L., Ruan X., Ruan Y., Lassmann T., Carninci P., Brown J.B., Lipovich L., Gonzalez J.M., Thomas M., Davis C.A., Shiekhattar R., Gingeras T.R., Hubbard T.J., Notredame C., Harrow J., Guigo R. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012, 22:1775-1789.
17. Cheng W., Zhang Z., Wang J. Long noncoding RNAs: new players in prostate cancer. Cancer Lett. 2013, 339:8-14.
18. Rinn J.L., Chang H.Y. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 2012, 81:145-166.
19. Gibb E.A., Brown C.J., Lam W.L. The functional role of long non-coding RNA in human carcinomas. Mol. Cancer 2011, 10:38.
20. Gutschner T., Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012, 9:703-719.
21. Wang F., Li X., Xie X., Zhao L., Chen W. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett. 2008, 582:1919-1927.
22. Ariel I., Lustig O., Schneider T., Pizov G., Sappir M., De-Groot N., Hochberg A. The imprinted H19 gene as a tumor marker in bladder carcinoma. Urology 1995, 45:335-338.
23. Luo M., Li Z., Wang W., Zeng Y., Liu Z., Qiu J. Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J. 2013, 280:1709-1716.
24. Luo M., Li Z., Wang W., Zeng Y., Liu Z., Qiu J. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett. 2013.
25. He W., Cai Q., Sun F., Zhong G., Wang P., Liu H., Luo J., Yu H., Huang J., Lin T. Linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer. Biochim. Biophys. Acta 2013.
26. Han Y., Liu Y., Nie L., Gui Y., Cai Z. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. Urology 2013, 81(209):e201-e207.
27. Ying L., Chen Q., Wang Y., Zhou Z., Huang Y., Qiu F. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol. BioSyst. 2012, 8:2289-2294.
28. Ying L., Huang Y., Chen H., Wang Y., Xia L., Chen Y., Liu Y., Qiu F. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol. BioSyst. 2013, 9:407-411.
29. Liu Z., Wang W., Jiang J., Bao E., Xu D., Zeng Y., Tao L., Qiu J. Downregulation of GAS5 promotes bladder cancer cell proliferation, partly by regulating CDK6. PLoS ONE 2013, 8:e73991.
30. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., Goodnough L.H., Helms J.A., Farnham P.J., Segal E., Chang H.Y. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323.
31. Wu W., Chan J.A. Understanding the role of long noncoding RNAs in the cancer genome. Next Generation Sequencing in Cancer Research - Decoding Cancer Genome 2013, 199-215. Springer, New York. W. Wu, H. Choudhry (Eds.).
32. Hansel D.E., Zhang Z., Petillo D., Teh B.T. Gene profiling suggests a common evolution of bladder cancer subtypes. BMC Med. Genomics 2013, 6:42.
33. Tanaka T., Miyazawa K., Tsukamoto T., Kuno T., Suzuki K. Pathobiology and chemoprevention of bladder cancer. J. Oncol. 2011, 2011:528353.
34. Dinger M.E., Amaral P.P., Mercer T.R., Pang K.C., Bruce S.J., Gardiner B.B., Askarian-Amiri M.E., Ru K., Solda G., Simons C., Sunkin S.M., Crowe M.L., Grimmond S.M., Perkins A.C., Mattick J.S. Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res. 2008, 18:1433-1445.
35. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.C., Hung T., Argani P., Rinn J.L., Wang Y., Brzoska P., Kong B., Li R., West R.B., van de Vijver M.J., Sukumar S., Chang H.Y. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
36. Prensner J.R., Chinnaiyan A.M. The emergence of lncRNAs in cancer biology. Cancer Discovery 2011, 1:391-407.
37. Kim K., Jutooru I., Chadalapaka G., Johnson G., Frank J., Burghardt R., Kim S., Safe S. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 2013, 32:1616-1625.
38. Lv X.B., Lian G.Y., Wang H.R., Song E., Yao H., Wang M.H. Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PLoS ONE 2013, 8:e63516.
39. Zhang Q., Su M., Lu G., Wang J. The complexity of bladder cancer: long noncoding RNAs are on the stage. Mol. Cancer 2013, 12:101.
40. Zhang Z., Hao H., Zhang C.J., Yang X.Y., He Q., Lin J. Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder cancer. Zhonghua yi xue za zhi 2012, 92:384-387.
41. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 2009, 10:155-159.
42. Liao Q., Liu C., Yuan X., Kang S., Miao R., Xiao H., Zhao G., Luo H., Bu D., Zhao H., Skogerbo G., Wu Z., Zhao Y. Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network. Nucleic Acids Res. 2011, 39:3864-3878.
43. Ponjavic J., Oliver P.L., Lunter G., Ponting C.P. Genomic and transcriptional co-localization of protein-coding and long non-coding RNA pairs in the developing brain. PLoS Genet. 2009, 5:e1000617.
44. Ying-Hao S., Qing Y., Lin-Hui W., Li G., Rong T., Kang Y., Chuan-Liang X., Song-Xi Q., Yao L., Yi X., Yu-Ming M. Monitoring gene expression profile changes in bladder transitional cell carcinoma using cDNA microarray. Urologic Oncol. 2002, 7:207-212.